Solanbridge Group, Inc. (SLNX) Stock Competitors & Peer Comparison
See (SLNX) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SLNX | $0.00 | +0.00% | 476K | N/A | N/A | N/A |
| MKGAF | $158.20 | +1.31% | 71.2B | 24.21 | $6.76 | +1.57% |
| MKKGY | $31.39 | -2.12% | 68.2B | 23.25 | $1.35 | +1.64% |
| IPSEY | $46.75 | +0.00% | 61.8B | 30.56 | $1.53 | +0.99% |
| TKPHF | $31.30 | +2.72% | 49.4B | 41.73 | $0.75 | +4.17% |
| HLNCF | $4.51 | +1.12% | 39.9B | 18.02 | $0.25 | +2.12% |
| SDZNY | $82.18 | +0.90% | 35.6B | 39.32 | $2.09 | +1.24% |
| TEVJF | $30.34 | +0.00% | 35.3B | 22.64 | $1.34 | N/A |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
Stock Comparison
SLNX vs MKGAF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, MKGAF has a market cap of 71.2B. Regarding current trading prices, SLNX is priced at $0.00, while MKGAF trades at $158.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 24.21. In terms of profitability, SLNX's ROE is +1.18%, compared to MKGAF's ROE of +0.08%. Regarding short-term risk, SLNX is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check MKGAF's competition here
SLNX vs MKKGY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, MKKGY has a market cap of 68.2B. Regarding current trading prices, SLNX is priced at $0.00, while MKKGY trades at $31.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 23.25. In terms of profitability, SLNX's ROE is +1.18%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, SLNX is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check MKKGY's competition here
SLNX vs IPSEY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, IPSEY has a market cap of 61.8B. Regarding current trading prices, SLNX is priced at $0.00, while IPSEY trades at $46.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 30.56. In terms of profitability, SLNX's ROE is +1.18%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, SLNX is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check IPSEY's competition here
SLNX vs TKPHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, TKPHF has a market cap of 49.4B. Regarding current trading prices, SLNX is priced at $0.00, while TKPHF trades at $31.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 41.73. In terms of profitability, SLNX's ROE is +1.18%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, SLNX is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check TKPHF's competition here
SLNX vs HLNCF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, HLNCF has a market cap of 39.9B. Regarding current trading prices, SLNX is priced at $0.00, while HLNCF trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 18.02. In terms of profitability, SLNX's ROE is +1.18%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, SLNX is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check HLNCF's competition here
SLNX vs SDZNY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SDZNY has a market cap of 35.6B. Regarding current trading prices, SLNX is priced at $0.00, while SDZNY trades at $82.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is 39.32. In terms of profitability, SLNX's ROE is +1.18%, compared to SDZNY's ROE of +0.10%. Regarding short-term risk, SLNX is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SDZNY's competition here
SLNX vs TEVJF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, TEVJF has a market cap of 35.3B. Regarding current trading prices, SLNX is priced at $0.00, while TEVJF trades at $30.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is 22.64. In terms of profitability, SLNX's ROE is +1.18%, compared to TEVJF's ROE of +0.21%. Regarding short-term risk, SLNX is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check TEVJF's competition here
SLNX vs TAIPY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, SLNX is priced at $0.00, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, SLNX's ROE is +1.18%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, SLNX is more volatile compared to TAIPY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check TAIPY's competition here
SLNX vs ESALY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, SLNX is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, SLNX's ROE is +1.18%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, SLNX is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check ESALY's competition here
SLNX vs BIOVF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, BIOVF has a market cap of 16.6B. Regarding current trading prices, SLNX is priced at $0.00, while BIOVF trades at $48.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 171.43. In terms of profitability, SLNX's ROE is +1.18%, compared to BIOVF's ROE of +0.02%. Regarding short-term risk, SLNX is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check BIOVF's competition here
SLNX vs SGIOY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SGIOY has a market cap of 14.6B. Regarding current trading prices, SLNX is priced at $0.00, while SGIOY trades at $8.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 11.95. In terms of profitability, SLNX's ROE is +1.18%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, SLNX is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SGIOY's competition here
SLNX vs SGIOF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SGIOF has a market cap of 13.6B. Regarding current trading prices, SLNX is priced at $0.00, while SGIOF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 10.67. In terms of profitability, SLNX's ROE is +1.18%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, SLNX is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SGIOF's competition here
SLNX vs IPSEF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, IPSEF has a market cap of 9.3B. Regarding current trading prices, SLNX is priced at $0.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, SLNX's ROE is +1.18%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, SLNX is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check IPSEF's competition here
SLNX vs ESALF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, ESALF has a market cap of 6.7B. Regarding current trading prices, SLNX is priced at $0.00, while ESALF trades at $23.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 28.09. In terms of profitability, SLNX's ROE is +1.18%, compared to ESALF's ROE of +0.04%. Regarding short-term risk, SLNX is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check ESALF's competition here
SLNX vs BCHMF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, BCHMF has a market cap of 6.5B. Regarding current trading prices, SLNX is priced at $0.00, while BCHMF trades at $87.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas BCHMF's P/E ratio is 35.08. In terms of profitability, SLNX's ROE is +1.18%, compared to BCHMF's ROE of +0.11%. Regarding short-term risk, SLNX is more volatile compared to BCHMF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check BCHMF's competition here
SLNX vs ESAIY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, ESAIY has a market cap of 6.5B. Regarding current trading prices, SLNX is priced at $0.00, while ESAIY trades at $5.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 27.24. In terms of profitability, SLNX's ROE is +1.18%, compared to ESAIY's ROE of +0.04%. Regarding short-term risk, SLNX is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check ESAIY's competition here
SLNX vs GZPHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, SLNX is priced at $0.00, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, SLNX's ROE is +1.18%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, SLNX is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check GZPHF's competition here
SLNX vs LVZPF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, SLNX is priced at $0.00, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, SLNX's ROE is +1.18%, compared to LVZPF's ROE of +0.14%. Regarding short-term risk, SLNX is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check LVZPF's competition here
SLNX vs HLUBF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, HLUBF has a market cap of 5.8B. Regarding current trading prices, SLNX is priced at $0.00, while HLUBF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 9.48. In terms of profitability, SLNX's ROE is +1.18%, compared to HLUBF's ROE of +0.15%. Regarding short-term risk, SLNX is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check HLUBF's competition here
SLNX vs HLBBF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, HLBBF has a market cap of 5.8B. Regarding current trading prices, SLNX is priced at $0.00, while HLBBF trades at $7.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 14.29. In terms of profitability, SLNX's ROE is +1.18%, compared to HLBBF's ROE of +0.15%. Regarding short-term risk, SLNX is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check HLBBF's competition here
SLNX vs SFOSF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SFOSF has a market cap of 5.8B. Regarding current trading prices, SLNX is priced at $0.00, while SFOSF trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 11.45. In terms of profitability, SLNX's ROE is +1.18%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, SLNX is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SFOSF's competition here
SLNX vs LABFF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, SLNX is priced at $0.00, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas LABFF's P/E ratio is 28.95. In terms of profitability, SLNX's ROE is +1.18%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, SLNX is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check LABFF's competition here
SLNX vs SMDPY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SMDPY has a market cap of 4.5B. Regarding current trading prices, SLNX is priced at $0.00, while SMDPY trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 5.82. In terms of profitability, SLNX's ROE is +1.18%, compared to SMDPY's ROE of +0.42%. Regarding short-term risk, SLNX is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SMDPY's competition here
SLNX vs SGFEF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, SLNX is priced at $0.00, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 20.62. In terms of profitability, SLNX's ROE is +1.18%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, SLNX is more volatile compared to SGFEF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SGFEF's competition here
SLNX vs DNPUF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, DNPUF has a market cap of 4.2B. Regarding current trading prices, SLNX is priced at $0.00, while DNPUF trades at $9.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 5.58. In terms of profitability, SLNX's ROE is +1.18%, compared to DNPUF's ROE of +0.42%. Regarding short-term risk, SLNX is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check DNPUF's competition here
SLNX vs HKMPY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, HKMPY has a market cap of 4.2B. Regarding current trading prices, SLNX is priced at $0.00, while HKMPY trades at $39.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 10.80. In terms of profitability, SLNX's ROE is +1.18%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, SLNX is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check HKMPY's competition here
SLNX vs HKMPF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, HKMPF has a market cap of 4.1B. Regarding current trading prices, SLNX is priced at $0.00, while HKMPF trades at $19.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 10.66. In terms of profitability, SLNX's ROE is +1.18%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, SLNX is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check HKMPF's competition here
SLNX vs APNHY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, APNHY has a market cap of 3.9B. Regarding current trading prices, SLNX is priced at $0.00, while APNHY trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is -35.08. In terms of profitability, SLNX's ROE is +1.18%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, SLNX is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check APNHY's competition here
SLNX vs APNHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, APNHF has a market cap of 3.9B. Regarding current trading prices, SLNX is priced at $0.00, while APNHF trades at $8.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is -34.80. In terms of profitability, SLNX's ROE is +1.18%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, SLNX is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check APNHF's competition here
SLNX vs CAMRF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CAMRF has a market cap of 3.5B. Regarding current trading prices, SLNX is priced at $0.00, while CAMRF trades at $58.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CAMRF's P/E ratio is 47.93. In terms of profitability, SLNX's ROE is +1.18%, compared to CAMRF's ROE of +0.16%. Regarding short-term risk, SLNX is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CAMRF's competition here
SLNX vs LBTSF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, SLNX is priced at $0.00, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, SLNX's ROE is +1.18%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, SLNX is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check LBTSF's competition here
SLNX vs CHSYF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, SLNX is priced at $0.00, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, SLNX's ROE is +1.18%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, SLNX is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CHSYF's competition here
SLNX vs INVVY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, SLNX is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, SLNX's ROE is +1.18%, compared to INVVY's ROE of -0.42%. Regarding short-term risk, SLNX is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check INVVY's competition here
SLNX vs IZQVF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, SLNX is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, SLNX's ROE is +1.18%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, SLNX is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check IZQVF's competition here
SLNX vs CURLF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CURLF has a market cap of 2.9B. Regarding current trading prices, SLNX is priced at $0.00, while CURLF trades at $10.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -25.79. In terms of profitability, SLNX's ROE is +1.18%, compared to CURLF's ROE of -0.13%. Regarding short-term risk, SLNX is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CURLF's competition here
SLNX vs HYPMY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, HYPMY has a market cap of 2.8B. Regarding current trading prices, SLNX is priced at $0.00, while HYPMY trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 8.10. In terms of profitability, SLNX's ROE is +1.18%, compared to HYPMY's ROE of +0.13%. Regarding short-term risk, SLNX is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check HYPMY's competition here
SLNX vs ULIHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, ULIHF has a market cap of 2.4B. Regarding current trading prices, SLNX is priced at $0.00, while ULIHF trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 7.75. In terms of profitability, SLNX's ROE is +1.18%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, SLNX is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check ULIHF's competition here
SLNX vs TCNNF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, TCNNF has a market cap of 2.2B. Regarding current trading prices, SLNX is priced at $0.00, while TCNNF trades at $11.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -28.87. In terms of profitability, SLNX's ROE is +1.18%, compared to TCNNF's ROE of -0.07%. Regarding short-term risk, SLNX is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check TCNNF's competition here
SLNX vs NPNKF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, SLNX is priced at $0.00, while NPNKF trades at $31.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 11.38. In terms of profitability, SLNX's ROE is +1.18%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, SLNX is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check NPNKF's competition here
SLNX vs HTSUF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, SLNX is priced at $0.00, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, SLNX's ROE is +1.18%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, SLNX is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check HTSUF's competition here
SLNX vs GTBIF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, GTBIF has a market cap of 2B. Regarding current trading prices, SLNX is priced at $0.00, while GTBIF trades at $8.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 16.61. In terms of profitability, SLNX's ROE is +1.18%, compared to GTBIF's ROE of +0.07%. Regarding short-term risk, SLNX is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check GTBIF's competition here
SLNX vs DMPHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, DMPHF has a market cap of 2B. Regarding current trading prices, SLNX is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, SLNX's ROE is +1.18%, compared to DMPHF's ROE of +0.21%. Regarding short-term risk, SLNX is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check DMPHF's competition here
SLNX vs ARSUF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, ARSUF has a market cap of 1.9B. Regarding current trading prices, SLNX is priced at $0.00, while ARSUF trades at $26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 18.55. In terms of profitability, SLNX's ROE is +1.18%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, SLNX is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check ARSUF's competition here
SLNX vs DUTV Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, SLNX is priced at $0.00, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas DUTV's P/E ratio is N/A. In terms of profitability, SLNX's ROE is +1.18%, compared to DUTV's ROE of -0.09%. Regarding short-term risk, SLNX is more volatile compared to DUTV. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check DUTV's competition here
SLNX vs HMDCF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, HMDCF has a market cap of 1.9B. Regarding current trading prices, SLNX is priced at $0.00, while HMDCF trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is 4.08. In terms of profitability, SLNX's ROE is +1.18%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, SLNX is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check HMDCF's competition here
SLNX vs TSMRF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, SLNX is priced at $0.00, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, SLNX's ROE is +1.18%, compared to TSMRF's ROE of +0.09%. Regarding short-term risk, SLNX is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check TSMRF's competition here
SLNX vs SHPHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, SLNX is priced at $0.00, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, SLNX's ROE is +1.18%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, SLNX is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SHPHF's competition here
SLNX vs NPPNY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, NPPNY has a market cap of 1.6B. Regarding current trading prices, SLNX is priced at $0.00, while NPPNY trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 8.84. In terms of profitability, SLNX's ROE is +1.18%, compared to NPPNY's ROE of +0.11%. Regarding short-term risk, SLNX is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check NPPNY's competition here
SLNX vs MITPF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, SLNX is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, SLNX's ROE is +1.18%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, SLNX is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check MITPF's competition here
SLNX vs KARBF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, SLNX is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, SLNX's ROE is +1.18%, compared to KARBF's ROE of N/A. Regarding short-term risk, SLNX is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check KARBF's competition here
SLNX vs CMOPF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CMOPF has a market cap of 1.5B. Regarding current trading prices, SLNX is priced at $0.00, while CMOPF trades at $85.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CMOPF's P/E ratio is -330.58. In terms of profitability, SLNX's ROE is +1.18%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, SLNX is more volatile compared to CMOPF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CMOPF's competition here
SLNX vs SWGHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, SLNX is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, SLNX's ROE is +1.18%, compared to SWGHF's ROE of +0.06%. Regarding short-term risk, SLNX is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SWGHF's competition here
SLNX vs EVOTF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, EVOTF has a market cap of 1.2B. Regarding current trading prices, SLNX is priced at $0.00, while EVOTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -5.27. In terms of profitability, SLNX's ROE is +1.18%, compared to EVOTF's ROE of -0.25%. Regarding short-term risk, SLNX is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check EVOTF's competition here
SLNX vs LJUIF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, SLNX is priced at $0.00, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, SLNX's ROE is +1.18%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, SLNX is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check LJUIF's competition here
SLNX vs BIOGY Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, SLNX is priced at $0.00, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, SLNX's ROE is +1.18%, compared to BIOGY's ROE of +0.26%. Regarding short-term risk, SLNX is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check BIOGY's competition here
SLNX vs CHIZF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CHIZF has a market cap of 1.1B. Regarding current trading prices, SLNX is priced at $0.00, while CHIZF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is -21.89. In terms of profitability, SLNX's ROE is +1.18%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, SLNX is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CHIZF's competition here
SLNX vs CASBF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CASBF has a market cap of 1.1B. Regarding current trading prices, SLNX is priced at $0.00, while CASBF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is 155.00. In terms of profitability, SLNX's ROE is +1.18%, compared to CASBF's ROE of -0.00%. Regarding short-term risk, SLNX is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CASBF's competition here
SLNX vs KSPHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, SLNX is priced at $0.00, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 12.45. In terms of profitability, SLNX's ROE is +1.18%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, SLNX is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check KSPHF's competition here
SLNX vs GNMLF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, SLNX is priced at $0.00, while GNMLF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 12.00. In terms of profitability, SLNX's ROE is +1.18%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, SLNX is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check GNMLF's competition here
SLNX vs GLASF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, GLASF has a market cap of 1B. Regarding current trading prices, SLNX is priced at $0.00, while GLASF trades at $13.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -20.22. In terms of profitability, SLNX's ROE is +1.18%, compared to GLASF's ROE of -0.26%. Regarding short-term risk, SLNX is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check GLASF's competition here
SLNX vs KKPCF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, SLNX is priced at $0.00, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, SLNX's ROE is +1.18%, compared to KKPCF's ROE of +0.01%. Regarding short-term risk, SLNX is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check KKPCF's competition here
SLNX vs TWAPF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, SLNX is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, SLNX's ROE is +1.18%, compared to TWAPF's ROE of +0.03%. Regarding short-term risk, SLNX is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check TWAPF's competition here
SLNX vs CSWYF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, SLNX is priced at $0.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, SLNX's ROE is +1.18%, compared to CSWYF's ROE of +0.12%. Regarding short-term risk, SLNX is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CSWYF's competition here
SLNX vs TRXPF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, SLNX is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, SLNX's ROE is +1.18%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, SLNX is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check TRXPF's competition here
SLNX vs SHEZF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SHEZF has a market cap of 689M. Regarding current trading prices, SLNX is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, SLNX's ROE is +1.18%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, SLNX is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SHEZF's competition here
SLNX vs AGYTF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, AGYTF has a market cap of 655.5M. Regarding current trading prices, SLNX is priced at $0.00, while AGYTF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -13.00. In terms of profitability, SLNX's ROE is +1.18%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, SLNX is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check AGYTF's competition here
SLNX vs KHTRF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, KHTRF has a market cap of 646M. Regarding current trading prices, SLNX is priced at $0.00, while KHTRF trades at $6.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is 164.75. In terms of profitability, SLNX's ROE is +1.18%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, SLNX is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check KHTRF's competition here
SLNX vs YIHCF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, SLNX is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, SLNX's ROE is +1.18%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, SLNX is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check YIHCF's competition here
SLNX vs AIHLF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, SLNX is priced at $0.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, SLNX's ROE is +1.18%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, SLNX is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check AIHLF's competition here
SLNX vs TRSSF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, SLNX is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, SLNX's ROE is +1.18%, compared to TRSSF's ROE of -0.76%. Regarding short-term risk, SLNX is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check TRSSF's competition here
SLNX vs BOIRF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, BOIRF has a market cap of 553.9M. Regarding current trading prices, SLNX is priced at $0.00, while BOIRF trades at $31.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 14.63. In terms of profitability, SLNX's ROE is +1.18%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, SLNX is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check BOIRF's competition here
SLNX vs PKBFF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, SLNX is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is N/A. In terms of profitability, SLNX's ROE is +1.18%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, SLNX is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check PKBFF's competition here
SLNX vs CCHWF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, SLNX is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, SLNX's ROE is +1.18%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, SLNX is more volatile compared to CCHWF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CCHWF's competition here
SLNX vs VRNOF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, SLNX is priced at $0.00, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, SLNX's ROE is +1.18%, compared to VRNOF's ROE of -0.31%. Regarding short-term risk, SLNX is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check VRNOF's competition here
SLNX vs PEXXF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, SLNX is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, SLNX's ROE is +1.18%, compared to PEXXF's ROE of N/A. Regarding short-term risk, SLNX is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check PEXXF's competition here
SLNX vs SWDCF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SWDCF has a market cap of 444.4M. Regarding current trading prices, SLNX is priced at $0.00, while SWDCF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 92.67. In terms of profitability, SLNX's ROE is +1.18%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, SLNX is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SWDCF's competition here
SLNX vs HUMDF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, HUMDF has a market cap of 430.9M. Regarding current trading prices, SLNX is priced at $0.00, while HUMDF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is 2.70. In terms of profitability, SLNX's ROE is +1.18%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, SLNX is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check HUMDF's competition here
SLNX vs ELTP Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, ELTP has a market cap of 382.3M. Regarding current trading prices, SLNX is priced at $0.00, while ELTP trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is 8.88. In terms of profitability, SLNX's ROE is +1.18%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, SLNX is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check ELTP's competition here
SLNX vs CRLBF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CRLBF has a market cap of 315.3M. Regarding current trading prices, SLNX is priced at $0.00, while CRLBF trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -2.34. In terms of profitability, SLNX's ROE is +1.18%, compared to CRLBF's ROE of -0.35%. Regarding short-term risk, SLNX is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CRLBF's competition here
SLNX vs CPHRF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CPHRF has a market cap of 299.6M. Regarding current trading prices, SLNX is priced at $0.00, while CPHRF trades at $11.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 9.96. In terms of profitability, SLNX's ROE is +1.18%, compared to CPHRF's ROE of +0.26%. Regarding short-term risk, SLNX is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CPHRF's competition here
SLNX vs GUERF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, SLNX is priced at $0.00, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas GUERF's P/E ratio is 8.19. In terms of profitability, SLNX's ROE is +1.18%, compared to GUERF's ROE of +0.04%. Regarding short-term risk, SLNX is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check GUERF's competition here
SLNX vs BHCCF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, SLNX is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, SLNX's ROE is +1.18%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, SLNX is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check BHCCF's competition here
SLNX vs NIKA Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, NIKA has a market cap of 211.8M. Regarding current trading prices, SLNX is priced at $0.00, while NIKA trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, SLNX's ROE is +1.18%, compared to NIKA's ROE of +0.27%. Regarding short-term risk, SLNX is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check NIKA's competition here
SLNX vs PLNHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, SLNX is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, SLNX's ROE is +1.18%, compared to PLNHF's ROE of +838111.55%. Regarding short-term risk, SLNX is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check PLNHF's competition here
SLNX vs CBWTF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CBWTF has a market cap of 156.2M. Regarding current trading prices, SLNX is priced at $0.00, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CBWTF's P/E ratio is 11.13. In terms of profitability, SLNX's ROE is +1.18%, compared to CBWTF's ROE of +0.16%. Regarding short-term risk, SLNX is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CBWTF's competition here
SLNX vs COPHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, SLNX is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, SLNX's ROE is +1.18%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, SLNX is more volatile compared to COPHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check COPHF's competition here
SLNX vs NWPN Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, SLNX is priced at $0.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas NWPN's P/E ratio is -0.04. In terms of profitability, SLNX's ROE is +1.18%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, SLNX is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for SLNX.Check NWPN's competition here
SLNX vs LOVFF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, LOVFF has a market cap of 116.6M. Regarding current trading prices, SLNX is priced at $0.00, while LOVFF trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas LOVFF's P/E ratio is 14.75. In terms of profitability, SLNX's ROE is +1.18%, compared to LOVFF's ROE of +0.09%. Regarding short-term risk, SLNX is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check LOVFF's competition here
SLNX vs BIOYF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, BIOYF has a market cap of 114.3M. Regarding current trading prices, SLNX is priced at $0.00, while BIOYF trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas BIOYF's P/E ratio is 17.84. In terms of profitability, SLNX's ROE is +1.18%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, SLNX is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check BIOYF's competition here
SLNX vs LPCUF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, SLNX is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, SLNX's ROE is +1.18%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, SLNX is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check LPCUF's competition here
SLNX vs GRUSF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, GRUSF has a market cap of 110.9M. Regarding current trading prices, SLNX is priced at $0.00, while GRUSF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas GRUSF's P/E ratio is 44.39. In terms of profitability, SLNX's ROE is +1.18%, compared to GRUSF's ROE of +0.01%. Regarding short-term risk, SLNX is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check GRUSF's competition here
SLNX vs AAWH Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, AAWH has a market cap of 109.6M. Regarding current trading prices, SLNX is priced at $0.00, while AAWH trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas AAWH's P/E ratio is -0.84. In terms of profitability, SLNX's ROE is +1.18%, compared to AAWH's ROE of +5.41%. Regarding short-term risk, SLNX is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check AAWH's competition here
SLNX vs CNVCF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, SLNX is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, SLNX's ROE is +1.18%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, SLNX is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check CNVCF's competition here
SLNX vs JUSHF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, JUSHF has a market cap of 101.8M. Regarding current trading prices, SLNX is priced at $0.00, while JUSHF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas JUSHF's P/E ratio is -1.42. In terms of profitability, SLNX's ROE is +1.18%, compared to JUSHF's ROE of +0.66%. Regarding short-term risk, SLNX is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check JUSHF's competition here
SLNX vs HLTRF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, HLTRF has a market cap of 98.5M. Regarding current trading prices, SLNX is priced at $0.00, while HLTRF trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -9.84. In terms of profitability, SLNX's ROE is +1.18%, compared to HLTRF's ROE of -0.17%. Regarding short-term risk, SLNX is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check HLTRF's competition here
SLNX vs MEDXF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, MEDXF has a market cap of 95.6M. Regarding current trading prices, SLNX is priced at $0.00, while MEDXF trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas MEDXF's P/E ratio is -148.00. In terms of profitability, SLNX's ROE is +1.18%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, SLNX is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check MEDXF's competition here
SLNX vs SHIEF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, SHIEF has a market cap of 85.6M. Regarding current trading prices, SLNX is priced at $0.00, while SHIEF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas SHIEF's P/E ratio is -4.00. In terms of profitability, SLNX's ROE is +1.18%, compared to SHIEF's ROE of +1.18%. Regarding short-term risk, SLNX is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check SHIEF's competition here
SLNX vs ABSCF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, ABSCF has a market cap of 78.1M. Regarding current trading prices, SLNX is priced at $0.00, while ABSCF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -37.33. In terms of profitability, SLNX's ROE is +1.18%, compared to ABSCF's ROE of +0.07%. Regarding short-term risk, SLNX is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check ABSCF's competition here
SLNX vs ORXOF Comparison June 2026
SLNX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLNX stands at 476K. In comparison, ORXOF has a market cap of 73.8M. Regarding current trading prices, SLNX is priced at $0.00, while ORXOF trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLNX currently has a P/E ratio of N/A, whereas ORXOF's P/E ratio is -1.64. In terms of profitability, SLNX's ROE is +1.18%, compared to ORXOF's ROE of -2.28%. Regarding short-term risk, SLNX is more volatile compared to ORXOF. This indicates potentially higher risk in terms of short-term price fluctuations for SLNX.Check ORXOF's competition here